Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spinal nociceptive pathways are the neural circuits within the spinal cord that process and relay pain signals from peripheral tissues to the central nervous system. These pathways begin in the dorsal horn, where primary afferent nociceptors (A-delta and C fibers) release neurotransmitters like glutamate and substance P to activate second-order neurons, including those of the spinothalamic tract [1]. This system is not a single molecular target but a complex network involving various ion channels (e.g., Cav2.2, Nav1.7) and receptors (e.g., NMDA, mu-opioid) that modulate signal intensity [2]. In pathological states, such as chronic or neuropathic pain, these pathways undergo 'central sensitization,' characterized by increased neuronal excitability and a lowered threshold for pain [3]. Therapeutic strategies targeting these pathways include the use of opioids to activate inhibitory receptors, NMDA antagonists to reduce excitability, and calcium channel blockers to inhibit neurotransmitter release [4]. Additionally, descending pathways from the brainstem provide top-down modulation, which can either inhibit or facilitate spinal nociceptive transmission [1]. Understanding these pathways is crucial for developing multi-modal analgesic strategies that address different components of the pain transmission process.
Modulation of synaptic transmission in the dorsal horn, inhibition of excitatory neurotransmitter release (e.g., glutamate, substance P), blockade of voltage-gated ion channels, and enhancement of descending inhibitory control [1][4].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spinal nociceptive pathways.